AHA: American Heart Association
Conference Coverage
PACT-HF: Transitional care derives no overall benefit
PHILADELPHIA –
Conference Coverage
Analyses clarify who benefits from ARNI-ARB combination
PHILADELPHIA –
Conference Coverage
ODYSSEY Outcomes: Alirocumab cut stroke, PAD, VTE
PHILADELPHIA – Prespecified outcomes from the alirocumab outcomes trial showed the drug significantly cut PAD and VTE events, as well as ischemic...
Conference Coverage
New hypertension performance measures boost 130/80 mm Hg target
PHILADELPHIA – Hypertension performance and quality measures from the AHA and ACC provide a guide for implementing the 2017 hypertension guideline...
Conference Coverage
Navigators improve medication adherence in HFrEF
PHILADELPHIA –
Conference Coverage
Mechanical circulatory support in PCI needs clearer guidance
PHILADELPHIA – Two studies found the Impella device in percutaneous coronary intervention led to worse outcomes than intra-aortic balloon pumps....
Conference Coverage
Bariatric surgery tied to fewer cerebrovascular events
PHILADELPHIA –
Conference Coverage
Genetic test stratified AFib patients with low CHA2DS2-VASc scores
A 32-locus genetic test classified AFib patients with low CHA2DS2-VASc scores into high– and low–stroke-risk subgroups.
Conference Coverage
New heart failure trial data presage guideline revisions
PHILADELPHIA –
Conference Coverage
Colchicine pre-PCI improves biomarkers, not injury risk
PHILADELPHIA – Oral colchicine before percutaneous coronary intervention didn’t prevent adverse events but improved inflammatory biomarkers.
Conference Coverage
Cardiac arrests peak with pollution in Japan
PHILADELPHIA –
Conference Coverage
Icosapent ethyl cost effective in REDUCE-IT analysis
PHILADELPHIA – Treatment with the fish-derived drug for CV event reduction is more effective and less costly than placebo.
Conference Coverage
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
Conference Coverage
Colchicine cut post-MI CVD events
PHILADELPHIA – Colchicine fulfilled the promise first seem in CANTOS that anti-inflammatory treatment can reduce cardiovascular disease events.
Conference Coverage
Treating LDL to below 70 reduces recurrent stroke
PHILADELPHIA – Results of TST, a rare cholesterol study in patients with a history of ischemic stroke, explore the benefits of treating to a lower...